Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThis updates the displayed software/page release revision from **v3.5.2** to **v3.5.3** without changing any of the clinical trial study content.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check39 days agoChange DetectedNo substantive changes are visible; the study details and eligibility criteria appear unchanged. Actionable items and sections remain the same across screenshots.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.5.0 has been applied, replacing the previous v3.4.3.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedThe page now shows a new revision tag v3.4.2 and removes the previous revision v3.4.1; core study details, eligibility criteria, and results remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.